Heartflow, a cardiac CT AI vendor, files for a $100 million IPO after notable adoption and revenue growth.
Key Details
- 1Heartflow filed SEC documents for a $100M IPO following positive coverage news for its AI CT software.
- 2Radiology benefits manager EviCore and proposed Medicare Fee Schedule support are expected to boost future adoption.
- 3Heartflow's CT-based platform has been used on over 400,000 patients, including 132,000 last year.
- 4Company reported $126 million in revenue for 2023, up 44% year-over-year, but posted a $32.3 million quarterly loss in early 2024.
- 5Market opportunity for Heartflow's AI solutions estimated at $5 billion in the U.S. annually.
- 6IPO proceeds will be used for debt payment, sales, R&D, and general operations.
Why It Matters
Heartflow's IPO marks a major milestone in the maturation of radiology-focused AI companies and demonstrates growing clinical and payer acceptance of imaging AI tools. The public funding and Medicare consideration signal greater integration of AI in CT-based cardiovascular diagnostics.
Source
Radiology Business
Related News
•AuntMinnie
Habitat AI Model Improves Risk Stratification of Lung Nodules on LDCT
A 'habitat' AI model outperforms standard 2D approaches in stratifying lung adenocarcinoma risk in subsolid nodules on low-dose CT scans.
•AuntMinnie
AI Model Uses Chest CT to Diagnose and Grade COPD Severity
A machine learning model based on chest CT images accurately diagnoses and grades the severity of COPD.
•Radiology Business
Better Medicine Raises $7M to Expand Radiology AI for Kidney Lesions
Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.